Avance Biosciences™, a globally recognized Contract Research Organization (CRO), is excited to announce our participation in the upcoming AAPS PharmSci 360 meeting, taking place from October 15-18, 2024. This premier event brings together industry professionals and academic leaders to discuss innovations in pharmaceutical sciences and explore the latest advancements in drug development. As a leading expert in GLP & GMP compliant biological assay development, validation, and sample testing services, we are eager to showcase our innovative solutions at this prestigious event.
- Bioanalytics: Method development, assay validation, and testing services for drug development.
- Preclinical Studies: Safety and efficacy testing using GLP-compliant methodologies.
- Clinical Studies: Support for clinical trials, focusing on bioanalytical assay development.
- Manufacturing and Analytical Characterization: Quality control testing for biologics and cell therapies, including potency, stability, and identity assessments.
Attendees of the AAPS PharmSci 360 meeting can expect to engage with our knowledgeable representatives who are eager to discuss how our innovative testing solutions can support your projects. Our team will be available to provide insights into our services, showcase our latest advancements in bioloics testing, and explore potential collaborations.
We invite you to visit our booth to learn more about how Avance Biosciences can help you navigate the complexities of drug development and achieve your regulatory goals. Join us as we connect with industry leaders and contribute to advancing pharmaceutical sciences at this vital event!
See you at AAPS PharmSci 360 – 2024!
When you partner with Avance Biosciences™, you gain a CRO partner that is creative, collaborative and dedicated to sound science with a focus on the regulatory requirements our partners require. Contact our technical staff to discuss how we can support you in your project!
